In this article, Carmichael McKinley Finn, Executive Director at Recovering Hope, licensed therapist, addiction counselor, and adjunct faculty member, examines the federal government’s decision to designate illicit fentanyl as a Weapon of Mass Destruction. Drawing on frontline clinical and leadership experience, the piece explores why this framing raises deep concerns within behavioral health, how it risks repeating past policy failures, and where it could, if applied with clear guardrails, shift accountability toward the supply chains that profit from addiction rather than the people who need care.

In this article, Carmichael McKinley Finn, Executive Director at Recovering Hope, licensed therapist, addiction counselor, and adjunct faculty member, examines the federal government’s decision to designate illicit fentanyl as a Weapon of Mass Destruction. Drawing on frontline clinical and leadership experience, the piece explores why this framing raises deep concerns within behavioral health, how it risks repeating past policy failures, and where it could, if applied with clear guardrails, shift accountability toward the supply chains that profit from addiction rather than the people who need care.

In this article, Carmichael McKinley Finn, Executive Director at Recovering Hope, licensed therapist, addiction counselor, and adjunct faculty member, examines the federal government’s decision to designate illicit fentanyl as a Weapon of Mass Destruction. Drawing on frontline clinical and leadership experience, the piece explores why this framing raises deep concerns within behavioral health, how it risks repeating past policy failures, and where it could, if applied with clear guardrails, shift accountability toward the supply chains that profit from addiction rather than the people who need care.

Medetomidine is now entering the illicit fentanyl supply, fundamentally changing the risks of overdose and withdrawal. Naloxone may reverse the opioid, but it does nothing for the powerful veterinary sedative that remains active in the body. As detox capacity shrinks, this collision between a more dangerous drug supply and a weakened treatment system is costing lives.